Folotyn is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Acrotech Biopharma Llc. The primary component is Pralatrexate.
| Product ID | 72893-005_192ac27b-5caa-4401-a06e-f168d5b8c5b6 | 
| NDC | 72893-005 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Folotyn | 
| Generic Name | Pralatrexate | 
| Dosage Form | Injection | 
| Route of Administration | INTRAVENOUS | 
| Marketing Start Date | 2009-09-24 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA022468 | 
| Labeler Name | Acrotech Biopharma LLC | 
| Substance Name | PRALATREXATE | 
| Active Ingredient Strength | 40 mg/2mL | 
| Pharm Classes | Folate Analog Metabolic Inhibitor [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2021-12-31 | 
| Marketing Start Date | 2009-09-24 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA022468 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2009-09-24 | 
| Ingredient | Strength | 
|---|---|
| PRALATREXATE | 40 mg/2mL | 
| SPL SET ID: | 9f3d9c4d-9386-4451-b712-0fbdc5478d8f | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 48818-001 | Folotyn | pralatrexate | 
| 72893-003 | Folotyn | pralatrexate | 
| 72893-005 | Folotyn | pralatrexate | 
| 65219-550 | Pralatrexate | Pralatrexate | 
| 65219-552 | Pralatrexate | Pralatrexate | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() FOLOTYN  78881722  3743409 Live/Registered  | 
        Allos Therapeutics, Inc.  2006-05-11  | 
![]() FOLOTYN  77939090  3887969 Dead/Cancelled  | 
        Allos Therapeutics, Inc.  2010-02-18  |